---
$id: https://graph.org.ai/products/commodity/51111912
$type: Product
source: UNSPSC
code: "51111912"
title: "Temoporfin"
class: "51111900"
classTitle: "Natural antineoplastic products"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Temoporfin

**UNSPSC Code**: 51111912
**Class**: [Natural antineoplastic products](Natural antineoplastic products.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a photosensitizing agent with the molecular formula C44H32N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FU21S769PF, chemically known as 3,3,3,3-(7,8-dihydroporphyrin-5,10,15,20-tetrayl)tetraphenol but generally known as temoporfin, which bears US NIH Compound Identifier 60751. European Medicines Agency schedules Temoporfin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10888MIG. The term TEMOPORFIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). World Health Organization schedules temoporfin in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, TEMOPORFIN remains the US FDA Preferred Term for this commodity. Temoporfin bears US NLM identifiers UMLS ID C0379149 and NCI Concept Code C1669. SMILES: OC1CC(C2=C3[NH]C(=C(C4=NC(=C(C5[NH]C(C(=C6N=C2CC6)C2CC(O)CCC2)CC5)C2CC(O)CCC2)C=C4)C2CC(O)CCC2)CC3)CCC1. .

